John Ramage

12.5k total citations · 1 hit paper
154 papers, 6.0k citations indexed

About

John Ramage is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, John Ramage has authored 154 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Epidemiology, 85 papers in Oncology and 58 papers in Neurology. Recurrent topics in John Ramage's work include Neuroendocrine Tumor Research Advances (89 papers), Lung Cancer Research Studies (60 papers) and Neuroblastoma Research and Treatments (57 papers). John Ramage is often cited by papers focused on Neuroendocrine Tumor Research Advances (89 papers), Lung Cancer Research Studies (60 papers) and Neuroblastoma Research and Treatments (57 papers). John Ramage collaborates with scholars based in United Kingdom, United States and Germany. John Ramage's co-authors include Rajaventhan Srirajaskanthan, Roger Williams, Ron Basuroy, Bernard Portmann, Andreas Pascher, Philippe Ruszniewski, Edward Gane, Mary H. Perdue, Diego Ferone and Babs G. Taal and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

John Ramage

148 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms

2016 330 citations John Ramage et al. Neuroendocrinology profile →

Peers

Countries citing papers authored by John Ramage

Since Specialization

Citations

This map shows the geographic impact of John Ramage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Ramage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Ramage more than expected).

Fields of papers citing papers by John Ramage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Ramage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Ramage. The network helps show where John Ramage may publish in the future.

Co-authorship network of co-authors of John Ramage

This figure shows the co-authorship network connecting the top 25 collaborators of John Ramage. A scholar is included among the top collaborators of John Ramage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Ramage. John Ramage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sarcopenia and Neuroendocrine Neoplasms 2024 ·Current Oncology Reports ·(unknown), Sarah Brown, Monique E. van Leerdam, Margot Tesselaar, John Ramage, Rajaventhan Srirajaskanthan	3
2	Sex Differences in the Survival of Patients with Neuroendocrine Neoplasms: A Comparative Study of Two National Databases 2024 ·Cancers ·(unknown), (unknown), Kandiah Chandrakumaran, John Ramage	2
3	The Quality of Life of Pseudomyxoma Peritonei Patients: A Scoping Review 2024 ·European Journal of Cancer Care ·(unknown), Debra Gray, John Ramage	2
4	Current Management of Neuroendocrine Tumour Liver Metastases 2024 ·Current Oncology Reports ·(unknown), (unknown), John Ramage, (unknown), Krishna Menon, Parthi Srinivasan, M.I. Elmasry, Nick Reed, Matthew Seager, Rajaventhan Srirajaskanthan	3
5	The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumours 2024 ·Journal of Neuroendocrinology ·(unknown), Monique E. van Leerdam, Margot Tesselaar, (unknown), Wendy Martin, Martin O. Weickert, Debashis Sarker, John Ramage, Rajaventhan Srirajaskanthan	7
6	Optimising Outcomes and Surveillance Strategies of Rectal Neuroendocrine Neoplasms 2023 ·Cancers ·Rajaventhan Srirajaskanthan, (unknown), (unknown), Mark R. Howard, John Ramage	7
7	Second Primary Malignancies in Patients with a Neuroendocrine Neoplasm in England 2023 ·Neuroendocrinology ·Beth Russell, Benjamin White, Brian Rous, Kwok Wong, (unknown), Rajaventhan Srirajaskanthan, Mieke Van Hemelrijck, John Ramage	2
8	Prevalence of Sarcopenia and Impact on Survival in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours 2023 ·Cancers ·(unknown), Monique E. van Leerdam, (unknown), Martin O. Weickert, John Ramage, Margot Tesselaar, Rajaventhan Srirajaskanthan	9
9	Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012–2018: A Retrospective, Population-Based Study 2023 ·Cancers ·Benjamin White, Beth Russell, Sebastiaan Remmers, Brian Rous, Kandiah Chandrakumaran, Kwok Wong, Mieke Van Hemelrijck, Rajaventhan Srirajaskanthan, John Ramage	11
10	Development of a quality of life questionnaire for patients with pancreatic neuroendocrine tumours (the PANNET module) 2022 ·Journal of Neuroendocrinology ·John Ramage, Elizabeth Friend, (unknown), Barbara King, Paz Fernández‐Ortega, Mairéad G. McNamara, Gregory Kaltsas, Massimo Falconi, (unknown), Jaume Capdevila, Simona Grozinsky‐Glasberg, Dalvinder Mandair, Eva‐Maria Gamper, Raj Srirajaskanthan, Martin O. Weickert, Debra Gray, (unknown)	4
11	Primary renal neuroendocrine neoplasms: A systematic literature review, report of four local cases, and original survival analysis of 63 patients from a national registry 2012–2018 2022 ·Journal of Neuroendocrinology ·(unknown), (unknown), Kieran Palmer, Benjamin White, Rajaventhan Srirajaskanthan, Kandiah Chandrakumaran, John Ramage	3
12	PWE-23 Liver transplant follow up appointments in secondary care: Costs and the patient experience 2021 ·Rebecca Smith, Abid Suddle, John Ramage	0
13	PWE-126 Survival and recurrent disease in patients with resected primary small bowel neuroendocrine tumours 2012 ·Gut ·Rajaventhan Srirajaskanthan, Alia Ahmed, John Ramage	2
14	Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study 2009 ·Endocrine Related Cancer ·Alia Ahmed, G. Turner, Barbara King, Louise Jones, David Culliford, David R. McCance, J. Ardill, Brian Johnston, G.J. Poston, M. Rees, M. Buxton‐Thomas, Martyn Caplin, John Ramage	215
15	Neuroendocrine tumour management: a team approach 2005 ·British Journal of Hospital Medicine ·(unknown), (unknown), John Ramage	9
16	Neoadjuvant chemotherapy after liver transplantation for hepatocellular carcinoma. 1994 ·PubMed ·P M Rizzi, Stephen Ryder, John Ramage, Edward Gane, (unknown), Nigel Heaton, Bernard Portmann, K. C. Tan, Roger Williams	10
17	Effect of immunologic reactions on rat intestinal epithelium 1988 ·Gastroenterology ·John Ramage, Andrzej Stanisz, (unknown), Richard H. Hunt, Mary H. Perdue	20
18	Small bowel and colonic permeability to 51Cr-EDTA in patients with active inflammatory bowel disease. 1988 ·PubMed ·(unknown), John Ramage, Jones Db, Stephen M. Collins, (unknown), (unknown)	79
19	Large single daily dose of histamine H2 receptor antagonist for duodenal ulcer. How much and when? A clinical pharmacological study. 1987 ·Gut ·Mark Deakin, Helen Glenny, John Ramage, (unknown), W. L. Burland, J G Williams	20
20	Effect of cimetidine and pirenzepine in combination on 24 hour intragastric acidity in subjects with previous duodenal ulceration. 1986 ·Gut ·J G Williams, Mark Deakin, John Ramage	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact